These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25304530)

  • 21. The future of cell therapies and brain repair: Parkinson's disease leads the way.
    Petit GH; Olsson TT; Brundin P
    Neuropathol Appl Neurobiol; 2014 Feb; 40(1):60-70. PubMed ID: 24372386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial.
    McRae C; Cherin E; Yamazaki TG; Diem G; Vo AH; Russell D; Ellgring JH; Fahn S; Greene P; Dillon S; Winfield H; Bjugstad KB; Freed CR
    Arch Gen Psychiatry; 2004 Apr; 61(4):412-20. PubMed ID: 15066900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
    Mercado R; Constantoyannis C; Mandat T; Kumar A; Schulzer M; Stoessl AJ; Honey CR
    Mov Disord; 2006 Sep; 21(9):1457-61. PubMed ID: 16721750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate placebo effect in Parkinson's disease--is the subjective relief accompanied by objective improvement?
    Fregni F; Boggio PS; Bermpohl F; Maia F; Rigonatti SP; Barbosa ER; Pascual-Leone A
    Eur Neurol; 2006; 56(4):222-9. PubMed ID: 17057382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions.
    Heumann R; Moratalla R; Herrero MT; Chakrabarty K; Drucker-Colín R; Garcia-Montes JR; Simola N; Morelli M
    J Neurochem; 2014 Aug; 130(4):472-89. PubMed ID: 24773031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teaching neurons to respond to placebos.
    Benedetti F; Frisaldi E; Carlino E; Giudetti L; Pampallona A; Zibetti M; Lanotte M; Lopiano L
    J Physiol; 2016 Oct; 594(19):5647-60. PubMed ID: 26861164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of the placebo effect and of conditioning.
    Haour F
    Neuroimmunomodulation; 2005; 12(4):195-200. PubMed ID: 15990450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of the placebo response.
    Benedetti F; Amanzio M
    Pulm Pharmacol Ther; 2013 Oct; 26(5):520-3. PubMed ID: 23370213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the placebo effect: contributions from neuroimaging.
    Lidstone SC; Stoessl AJ
    Mol Imaging Biol; 2007; 9(4):176-85. PubMed ID: 17334853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of placebo assignment in clinical trials of Parkinson's disease.
    Goetz CG; Janko K; Blasucci L; Jaglin JA
    Mov Disord; 2003 Oct; 18(10):1146-9. PubMed ID: 14534918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future and current surgical therapies in Parkinson's disease.
    Betchen SA; Kaplitt M
    Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mind matters: placebo enhances reward learning in Parkinson's disease.
    Schmidt L; Braun EK; Wager TD; Shohamy D
    Nat Neurosci; 2014 Dec; 17(12):1793-7. PubMed ID: 25326691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of mind on brain activity: evidence from neuroimaging studies of psychotherapy and placebo effect.
    Beauregard M
    Nord J Psychiatry; 2009; 63(1):5-16. PubMed ID: 19023697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Deep brain stimulation for Parkinson's disease and dystonia].
    Yokochi F
    Brain Nerve; 2009 Apr; 61(4):473-83. PubMed ID: 19378817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Placebo, placebo effect and clinical trials].
    de la Fuente-Fernández R
    Neurologia; 2007 Mar; 22(2):69-71. PubMed ID: 17323230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining functional imaging with brain stimulation in Parkinson's disease.
    Obeso I; Ray NJ; Antonelli F; Cho SS; Strafella AP
    Int Rev Psychiatry; 2011 Oct; 23(5):467-75. PubMed ID: 22200136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice.
    Mestre TA; Shamy M; Benedetti F; Lang AE
    Mov Disord; 2018 Aug; 33(8):1195-1203. PubMed ID: 30145820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural grafting in Parkinson's disease Problems and possibilities.
    Brundin P; Barker RA; Parmar M
    Prog Brain Res; 2010; 184():265-94. PubMed ID: 20887880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.